4-Bromomethcathinone
Psychoactive drug and research chemical
From Wikipedia, the free encyclopedia
4-Bromomethcathinone (4-BMC), also known as brephedrone, is a psychoactive drug and research chemical of the phenethylamine, amphetamine, and cathinone chemical classes. It acts as a serotonin-norepinephrine-dopamine releasing agent (SNDRA), and to a lesser degree, as a serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI).[1][2] Cathinones, including 4-BMC, possess neurotoxic and cytotoxic properties.[3]
Other names4-BMC; Brephedrone
| Clinical data | |
|---|---|
| Other names | 4-BMC; Brephedrone |
| Legal status | |
| Legal status | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C10H12BrNO |
| Molar mass | 242.116 g·mol−1 |
| 3D model (JSmol) | |
| Chirality | Racemic mixture |
| |
| |
| | |